India\u2019s pharmaceutical and healthcare sector has always played a critical role, both domestically and globally. Known as the \u201cpharmacy of the world,\u201d the country is a leading supplier of affordable generic medicines and vaccines. However, the COVID-19 pandemic highlighted vulnerabilities in the supply chain, particularly the dependence on imported <\/p>\n\n\n\n
Active Pharmaceutical Ingredients (APIs) and certain categories of medical devices. To address this, the Government of India launched a comprehensive package aimed at boosting domestic production of APIs and medical devices. This initiative not only supports self-reliance under the Atmanirbhar Bharat vision but also creates immense opportunities for entrepreneurs and startups to participate in a sector that is vital for public health and economic growth.<\/p>\n\n\n\n